FNCC FCM FMBA of Russia Scientific and Clinical Center for Physico-Chemical Medicine

The purpose of the FGBU FNCC FCM FMBA of Russia is to conduct biomedical research, gain knowledge about the mechanisms of pathogenesis of human diseases, develop and introduce modern technologies for prevention, diagnosis and treatment into medical practice; creation of algorithms for personalized medicine; providing primary health care, specialized, including high-tech, medical care to employees of organizations of certain industries with especially dangerous working conditions, including those with occupational diseases, and to the population of certain territories served by the FMBA of Russia, athletes of sports teams of the Russian Federation; organization of emergency medical aid in case of emergency situations at enterprises using physical, chemical and toxic substances in the technological process; advisory and diagnostic assistance to organizations involved in their activities with the use of poisons and toxic substances; Providing medical assistance to citizens of the Russian Federation within the framework of the Territorial Program of State Guarantees for the Provision of Free Medical Care to Citizens.

History

2020: Presentation of reagents to the Indicator-Bio analyzer for the detection of coronavirus

On April 10, 2020, the Federal Scientific and Clinical Center for Physical and Chemical Medicine (FNCC FKM) of the Federal Medical and Biological Agency (FMBA) presented chips and reagents for the Indicator-BIO analyzer. They allow you to identify dangerous viruses in biological fluids in 15 minutes, including the COVID-19 coronavirus. The Indicator-BIO device was developed by specialists from the Troitsky Engineering Center company, which is part of the TechnoSpark Group, a subsidiary of the Infrastructure and Educational Programs Fund (FIOP) of the RUSNANO Group. Read more here.

2016: Skin Bank Plan

At the end of November 2016, it became known about the creation in Russia of a bank of human skin, which the immune system of patients will perceive as their own. Izvestia writes about this.

The division of the Federal Medical and Biological Agency - FNCC of Physical and Chemical Medicine (FNCC FCM) - has developed a technology for growing artificial skin with reduced immunogenicity necessary for the treatment of burn patients.

A bank of human skin is created in Russia, which the immune system of patients will perceive as their own

One of our projects is the preparation of samples or skin preparations that will have very low immunogenicity, "says Vadim Govorun, head of the FCC FCM. - Current gene cell technologies allow the growth of non-immune response skin. The drug is made from the cells of some people, and will treat others without causing rejection by the body. Thus, we can avoid the main problem arising from organ transplantation.

Govorun claims that frozen skin will be able to be stored for a long time, since its cells, after thawing in culture medium, come to life, making the skin suitable for transplantation. The research center notes that the implemented analogues of the development do not exist at the moment.

The FNCC wants to put the production of drugs for such skin on stream so that it can be stored for future use and used as needed - for example, victims of burns in patients, when there is no time to grow transplants from the cells of the patients themselves or there is no way to transplant their own skin.

According to data, Rosstat about 300 thousand cases of thermal and chemical burns are recorded annually in Russia. This represents about 7% of all superficial injury cases.

By mid-2017, after passing clinical trials and the start of mass production of the drug, it is planned to create a federal skin bank.^[1]

Notes